2023 annual financial data

Enliven Therapeutics 2023 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -83.53M USD and net income was -71.58M USD.
Operating cash flow was -61.27M USD.

Get free Enliven Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-83.53M USD
Net income
-71.58M USD
Operating cash flow
-61.27M USD